Delex Therapeutics, Inc.
9B03N011
-
- $3.99
-
- $3.99
Publisher Description
Delex Therapeutics Inc. researches and develops drug delivery methods - specifically in pain management - called rapid onset and sustained effect delivery system. The company is seeking funds to support its research and development. A partner at a venture firm that focuses on companies in the health care and biotechnology sectors must assess the investment merits of Delex Therapeutics as it embarks on phase II clinical trials.
GENRE
Business & Personal Finance
RELEASED
2003
November 28
LANGUAGE
EN
English
LENGTH
17
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
1.3
MB
Ontario Formulary
2005
Agennix AG Gets Positive Results from Talactoferrin Trial
2010
Solnyx Pharmaceuticals: The Atoxeril Clinical Trial
2005
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
2021
A Handbook of Artificial Intelligence in Drug Delivery
2023
How Drug Testing Works
2022